Literature DB >> 26109215

Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter].

Henna Cederberg1, Markku Laakso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26109215     DOI： 10.1007/s00125-015-3674-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

Review 1.  Do statins beneficially or adversely affect glucose homeostasis?

Authors:  Michael S Kostapanos; George L Liamis; Haralampos J Milionis; Moses S Elisaf
Journal:  Curr Vasc Pharmacol       Date:  2010-09       Impact factor: 2.719

2.  Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter].

Authors:  Henna Cederberg; Markku Laakso
Journal:  Diabetologia       Date:  2015-06-25       Impact factor: 10.122

3.  Pharmacotherapy: Statins and new-onset diabetes--the important questions.

Authors:  David Preiss; Naveed Sattar
Journal:  Nat Rev Cardiol       Date:  2012-02-14       Impact factor: 32.419

4.  Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.

Authors:  Henna Cederberg; Alena Stančáková; Nagendra Yaluri; Shalem Modi; Johanna Kuusisto; Markku Laakso
Journal:  Diabetologia       Date:  2015-03-10       Impact factor: 10.122

5.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Authors:  Daniel I Swerdlow; David Preiss; Karoline B Kuchenbaecker; Michael V Holmes; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Stefan Stender; Paul C D Johnson; Robert A Scott; Maarten Leusink; Niek Verweij; Stephen J Sharp; Yiran Guo; Claudia Giambartolomei; Christina Chung; Anne Peasey; Antoinette Amuzu; KaWah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; Yun R Li; Gordon Lowe; John Gallacher; Marlene C W Stewart; Ioanna Tzoulaki; Sarah G Buxbaum; Daphne L van der A; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Urszula Stepaniak; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Fabrizio Veglia; Ian Ford; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Pim A de Jong; Ale Algra; Wilko Spiering; Anke H Maitland-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Charles B Eaton; Jennifer G Robinson; David Duggan; John Kjekshus; John R Downs; Antonio M Gotto; Anthony C Keech; Roberto Marchioli; Gianni Tognoni; Peter S Sever; Neil R Poulter; David D Waters; Terje R Pedersen; Pierre Amarenco; Haruo Nakamura; John J V McMurray; James D Lewsey; Daniel I Chasman; Paul M Ridker; Aldo P Maggioni; Luigi Tavazzi; Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; JoAnn E Manson; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Pamela J Schreiner; Myriam Fornage; David S Siscovick; Mary Cushman; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Susan Redline; Sanjay R Patel; John C Whittaker; Anders Hamsten; Joseph A Delaney; Caroline Dale; Tom R Gaunt; Andrew Wong; Diana Kuh; Rebecca Hardy; Sekar Kathiresan; Berta A Castillo; Pim van der Harst; Eric J Brunner; Anne Tybjaerg-Hansen; Michael G Marmot; Ronald M Krauss; Michael Tsai; Josef Coresh; Ronald C Hoogeveen; Bruce M Psaty; Leslie A Lange; Hakon Hakonarson; Frank Dudbridge; Steve E Humphries; Philippa J Talmud; Mika Kivimäki; Nicholas J Timpson; Claudia Langenberg; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Alex P Reiner; Brendan J Keating; Aroon D Hingorani; Naveed Sattar
Journal:  Lancet       Date:  2014-09-24       Impact factor: 79.321

6.  Statins and risk of treated incident diabetes in a primary care population.

Authors:  Nur Lisa Zaharan; David Williams; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

7.  Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.

Authors:  M S Kostapanos; H J Milionis; A-D Agouridis; C V Rizos; M S Elisaf
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503

8.  Risk of incident diabetes among patients treated with statins: population based study.

Authors:  Aleesa A Carter; Tara Gomes; Ximena Camacho; David N Juurlink; Baiju R Shah; Muhammad M Mamdani
Journal:  BMJ       Date:  2013-05-23
  8 in total
  3 in total

1.  Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter].

Authors:  Henna Cederberg; Markku Laakso
Journal:  Diabetologia       Date:  2015-06-25       Impact factor: 10.122

2.  Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells.

Authors:  Vishal A Salunkhe; Olof Elvstam; Lena Eliasson; Anna Wendt
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

3.  Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients.

Authors:  Daniel Margerie; Philippe Lefebvre; Violeta Raverdy; Uwe Schwahn; Hartmut Ruetten; Philip Larsen; Alain Duhamel; Julien Labreuche; Dorothée Thuillier; Bruno Derudas; Céline Gheeraert; Hélène Dehondt; Quentin Dhalluin; Jérémy Alexandre; Robert Caiazzo; Pamela Nesslany; Helene Verkindt; François Pattou; Bart Staels
Journal:  BMC Med Genomics       Date:  2019-06-03       Impact factor: 3.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.